F.A.Q.

2. Which psychedelics are used in therapy?

In psychedelic-assisted therapy, several psychedelics have been studied and utilized, each with its own unique properties and effects. The most commonly studied psychedelics in therapeutic settings include:

1. Psilocybin: Psilocybin is the active compound found in certain species of mushrooms, often referred to as "magic mushrooms." It is known for its hallucinogenic and introspective effects. Psilocybin-assisted therapy has been explored for the treatment of depression, anxiety, addiction, and end-of-life distress.

2. MDMA: MDMA, also known as ecstasy or molly, is a synthetic compound that produces empathogenic and entactogenic effects. It is typically associated with increased emotional openness and feelings of love and connection. MDMA-assisted therapy has shown promise in the treatment of post-traumatic stress disorder (PTSD) and has undergone advanced clinical trials.

3. LSD: Lysergic acid diethylamide (LSD) is a potent synthetic psychedelic that gained popularity in the 1960s. It induces profound alterations in perception, cognition, and consciousness. While LSD research was limited for several decades, there has been a resurgence of interest in recent years, particularly in exploring its potential therapeutic applications.

4. Ayahuasca: Ayahuasca is a plant-based psychedelic brew traditionally used in indigenous Amazonian rituals. It contains the psychoactive compound dimethyltryptamine (DMT). Ayahuasca ceremonies, often facilitated by trained shamans, have gained attention for their potential therapeutic benefits, particularly in the areas of trauma healing and spiritual exploration.

5. Ibogaine: Ibogaine is derived from the root bark of the Tabernanthe iboga shrub and has powerful hallucinogenic properties. It has been studied as a potential treatment for substance use disorders, particularly opioid addiction. However, its use requires careful medical supervision due to potential cardiac side effects.

It's important to note that the therapeutic use of psychedelics is still an emerging field, and research is ongoing. These substances are typically administered in controlled and supportive therapeutic settings under the guidance of trained professionals. The specific psychedelic used, dosage, and therapeutic approach may vary depending on the individual's condition, the therapeutic goals, and the legal and ethical guidelines of the jurisdiction in which the therapy takes place.